Treatment of cutaneous ulcer using platelet-rich plasma

Treatment of cutaneous ulcer using platelet-rich plasma - PRP therapy for cutaneous ulcer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009860

Enrollment

Registered

2013-01-24

Start date

2013-02-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cutaneous ulcer

Interventions

application of PRP to ulcer

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.refractory cutaneous ulcer 2.written informed consent

Exclusion criteria

Exclusion criteria: 1.local infection 2.malignancies on the treatment site 3.thrombocytopenia(<50,000/micro-l) 4.difficulty in blood collection around 50ml 5.others judged inappropriate

Design outcomes

Primary

Measure	Time frame
condition of cutaneous ulcer	—

Countries

Japan

Contacts

Public ContactTakeshi Tamaki

National Center for Global Health and Medicine Center Hospital Department of Dermatology

ttamaki@hosp.ncgm.go.jp0332027181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026